YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Ajanta Pharma
Ajanta Pharma
BSE: 532331NSE: AJANTPHARMISIN: INE031B01049

30th-Apr-2021 16:25Source: BSE

Ajanta Pharma -
Outcome Of Board Meeting

Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following:

1. Press Release;
2. Audited Consolidated Financial Results for the quarter and year ended 31st March 2021 along with Auditors' report with unmodified opinion;
3. Audited Standalone Financial Results for the quarter and year ended 31st March 2021 along with Auditors' report with unmodified opinion;
4. Investor's presentation.

Separate disclosure under Regulation 30 is being filed shortly.

We shall inform in due course, date of the 42nd Annual General Meeting to be held for the year ended 31st March 2021.

Meeting of the Board of Directors commenced at 2.00 p.m. and concluded at 4.00 p.m.

Kindly take the above on your records.

Sections